Trial Profile
Bioavailability study of two teriparatide formulations in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Mar 2016
Price :
$35
*
At a glance
- Drugs Teriparatide (Primary)
- Indications Osteoporosis
- Focus Adverse reactions; Pharmacokinetics
- 28 Mar 2016 New trial record
- 23 Mar 2016 Results published in the International Journal of Clinical Pharmacology and Therapeutics